Showing 711-720 of 2742 results for "".
MATV News: ASAPS Stats; Facial Rejuvenation Meeting Highlights; Millennials and Aesthetics; Tattoo Removal Misperceptions
https://modernaesthetics.com/series/matv-news/matv-news-asaps-stats-facial-rejuvenation-meeting-highlights-millennials-and-aesthetics-tattoo-removal-misperceptions/33277/New data from the American Society for Aesthetic Plastic Surgery show surgical procedures are still very much in demand, this year's American Academy of Facial Plastic and Reconstructive Surgery Facial Rejuvenation Meeting highlighted the latest improvements in aesthetic medicine and reconstructiveYou Got Hit with a Slew of Really Bad Reviews... What Now?
https://modernaesthetics.com/ma-issues-index/2018-mar-apr/you-got-hit-with-a-slew-of-really-bad-reviews-what-now/34156/Bad reviews happen to good doctors. Our experts share tips on how to rise above.How to Sharpen Your Social Media Strategy
https://modernaesthetics.com/ma-issues-index/2018-mar-apr/how-to-sharpen-your-social-media-strategy/34150/Don't just have a “presence.” Meet measurable goals and grow your practice.MATV News: ASPS News; Botox Biosimilar; CareCredit Enters MedSpa Market; Medical Spa Show Update
https://modernaesthetics.com/series/matv-news/matv-news-asps-news-botox-biosimilar-credit-credit-enters-medspa-market-medical-spa-show-update/33284/Plastic Surgery is on the rise, according to new stats from the American Society of Plastic Surgeons, Mylan and Revance are partnering to develop and market a Botox biosimilar, CareCredit is expanding into the day and medical spa markets. Also, a recap of the America Med Spa Association's first everLet's Play Telephone
https://modernaesthetics.com/ma-issues-index/2018-jan-feb/lets-play-telephone/34188/Telephone etiquette matters … a lot. How does your staff stack up?How Would You Spend $10,000 on Patient Accrual?
https://modernaesthetics.com/ma-issues-index/2018-jan-feb/how-would-you-spend-10000-on-patient-accrual/34189/You have $10,000 to spend for patient accrual in Q1 2018. How do you spend it and why?MATV News: Scar Wars; New CoolSculpting Campaign Focuses on Men; AAFPRS Trends
https://modernaesthetics.com/series/matv-news/matv-news-scar-wars-new-coolsculpting-campaign-focuses-on-men-aafprs-trends/33290/New research shows the importance of developing scar measures that balance perceptions of patients and physicians, CoolSculpting launches new "Not Cool vs. Cool" campaign with a focus on men, and a look at the results of the annual survey of the American Academy of Facial Plastic and ReconstructiveMATV News: RT002 Phase 3 Results; Expanded Indication for CoolSculpting; Safer Gluteal Fat Grafting
https://modernaesthetics.com/series/matv-news/matv-news-rt002-phase-3-results-expanded-indication-for-coolsculpting-safer-gluteal-fat-grafting/33293/The Describe PFD Patch is now FDA cleared for all commonly used lasers for tattoo removal, RT002 delivers positive top-line results in alleviating moderate-to-severe glabellar lines in Phase 3 trials with duration of effect up to 6 months, and new recommendations are released by ASERF's Gluteal FatHandling Negative Reviews in the Internet Age
https://modernaesthetics.com/ma-issues-index/2017-nov-dec/handling-negative-reviews-in-the-internet-age/34208/Respond, ignore it, or call your attorney? It depends.The F Word
https://modernaesthetics.com/ma-issues-index/2017-sept-oct/the-f-word/34230/What four-letter word instills fear and loathing in the hearts of all doctors? The answer: FREE.